A Phase 3 Randomized, Double-Blind Study of Nivolumab Monotherapy or Nivolumab Combined with Ipilimumab vs Placebo in Participants with Localized Renal Cell Carcinoma Who Underwent Radical or Partial Nephrectomy and Who Are at High Risk of Relapse
| Title | A Phase 3 Randomized, Double-Blind Study of Nivolumab Monotherapy or Nivolumab Combined with Ipilimumab vs Placebo in Participants with Localized Renal Cell Carcinoma Who Underwent Radical or Partial Nephrectomy and Who Are at High Risk of Relapse |
|---|---|
| Description | Abstract publication in ESMO |
| Organism | Homo sapiens |
| Data Type | Biomarker Data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA010775 |
| Release Date | 2022-09-09 |
| Submitter | JIAN HUANG (hjgcp2017@163.com) |
| Organization | Sun Yat-sen Memorial Hospital, Sun Yat-sen University |
| Submission Date | 2022-07-25 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX001379-01 | CA209-914 ESMO 2022 abstract | 1 | Biomarker Data | 165.3 KB | zip | 0 | Controlled |